Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.

PubWeight™: 3.22‹?› | Rank: Top 1%

🔗 View Article (PMID 32241793)

Published in Ann Rheum Dis on April 02, 2020

Authors

Sara Monti1, Silvia Balduzzi2, Paolo Delvino3, Elisa Bellis3, Verdiana Serena Quadrelli3, Carlomaurizio Montecucco3

Author Affiliations

1: Rheumatology Department, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy sara.saramonti@gmail.com.
2: Rheumatology Department, IRCCS Policlinico San Matteo, Pavia, Italy.
3: Rheumatology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Associated clinical trials:

Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe (Euro-COVIMID) | NCT04397237

Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants (CORhum) | NCT04426279